keyword
MENU ▼
Read by QxMD icon Read
search

The Lancet Oncology

keyword
https://www.readbyqxmd.com/read/28368245/colorectal-cancer-a-disease-of-the-young
#1
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
April 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28368244/preventable-cancer-off-limits-for-commonwealth-meeting
#2
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
April 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28349495/a-novel-report-on-the-use-of-an-oncology-zygomatic-implant-retained-maxillary-obturator-in-a-paediatric-patient
#3
Amit Dattani, David Richardson, Chris J Butterworth
This report details the use of zygomatic oncology osseointegrated implants to support and retain a maxillary obturator in a 13-year-old male patient who underwent a right-sided hemi-maxillectomy (Brown Class 2b) (Brown and Shaw, Lancet Oncol 11:1001-8, 2010) for a myxoid spindle cell carcinoma. At the time of maxillary resection, two zygomatic oncology implants were inserted into the right zygomatic body and subsequently utilised to provide in-defect support and retention for a bar-retained maxillary acrylic obturator prosthesis, which restored the patient's aesthetics and function to a very high level...
December 2017: International Journal of Implant Dentistry
https://www.readbyqxmd.com/read/28271857/mind-the-gap-charity-and-crowdfunding-in-health-care
#4
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
March 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28214403/china-s-health-trajectory-in-2017
#5
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
February 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28050393/metronomic-chemotherapy-seems-prowess-to-battle-against-cancer-in-current-scenario
#6
Prema Muthusamy, Krishnan Vengadaragava Chary, G K Nalini
INTRODUCTION: Metronomic chemotherapy is an emerging method of chemotherapy. Metronomic 'lowdose' chemotherapy regimen induces tumour dormancy and reduces cancer resistance against anticancer drugs. It tends to improve overall success rate of cancer chemotherapy than conventional cyclical regimen. AIM: The aim of this systemic review was to provide comprehensive data of metronomic chemotherapy trials, regimens used and it's outcome in cancer therapeutics. MATERIALS AND METHODS: Fifty chemotherapy trial data were searched sequentially from web...
November 2016: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/28049567/cannabis-high-time-for-evidence-based-policies
#7
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
January 2017: Lancet Oncology
https://www.readbyqxmd.com/read/28048284/su-f-p-08-medical-physics-perspective-on-radiation-therapy-quality-and-safety-considerations-in-low-income-settings
#8
J Van Dyk, A Meghzifene
PURPOSE: The last few years have seen a significant growth of interest in the global radiation therapy crisis. Various organizations are quantifying the need and providing aid in support of addressing the shortfall existing in many low-to-middle income countries (LMICs). The Lancet Oncology Commission report (Lancet Oncol. Sep;16(10):1153-86, 2015) projects a need of 22,000 new medical physicists in LMICs by 2035 if there is to be equal access globally. With the tremendous demand for new facilities, equipment and personnel, it is very important to recognize quality and safety considerations and to address them directly...
June 2016: Medical Physics
https://www.readbyqxmd.com/read/28040092/global-access-to-radiotherapy-in-low-and-middle-income-countries
#9
M Abdel-Wahab, E Fidarova, A Polo
Over the last 60 years, the International Atomic Energy Agency (IAEA) has been working to introduce, expand and improve radiotherapy services, working with partners such as the World Health Organization (WHO) to improve cancer diagnosis, treatment, care and control through collective action in low- and middle-income countries (LMICs). The Lancet Oncology Commission on radiotherapy published a report that defined five calls for action to expand global access to radiotherapy, drawing on the previous work of the Global Taskforce on Radiotherapy for Cancer Control...
February 2017: Clinical Oncology: a Journal of the Royal College of Radiologists
https://www.readbyqxmd.com/read/27924743/drug-approval-by-regulators-who-watches-the-watchers
#10
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
December 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27871732/crisis-point-for-radiology-and-oncology-workforces
#11
EDITORIAL
The Lancet
No abstract text is available yet for this article.
November 19, 2016: Lancet
https://www.readbyqxmd.com/read/27846913/induction-chemotherapy-for-locoregionally-advanced-nasopharyngeal-carcinoma
#12
Wen-Fei Li, Lei Chen, Ying Sun, Jun Ma
The value of adding induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) for the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. In our recent article entitled "Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial" published in the Lancet Oncology, we reported the results of a phase III, multicenter, randomized controlled trial comparing cisplatin, 5-fluorouracil, and docetaxel (TPF) IC plus CCRT versus CCRT alone in patients with T3-4N1/TxN2-3M0 NPC (ClinicalTrials...
November 15, 2016: Chinese Journal of Cancer
https://www.readbyqxmd.com/read/27842898/president-trump-into-the-unknown%C3%A2
#13
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
December 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27819226/cancer-drug-safety-time-to-re-focus-on-tackling-adverse-effects
#14
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
November 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27733256/making-paediatric-precision-oncology-a-reality
#15
The Lancet Oncology
No abstract text is available yet for this article.
October 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27599132/measuring-the-quality-of-cancer-care-in-uk-hospitals
#16
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
September 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27585992/assessing-second-look-tumour-resectability-in-childhood-posterior-fossa-ependymoma-a-centralised-review-panel-and-staging-tool-for-future-studies
#17
Christopher P Millward, Conor Mallucci, Tim Jaspan, Donald Macarthur, Richard Heyward, Tim Cox, Kung Chong, Richard G Grundy
PURPOSE: To improve uniformity in radiological review/reporting and discussion of surgical resection status in the forthcoming SIOP Ependymoma II trial, a central review of imaging and resection status will be carried out prior to treatment stratification. We present a review of surgical decision-making from the UKCCSG/SIOP Ependymoma trial for very young children (<3 years) (Lancet Oncol 8:696-705, 2007) and propose a primary surgical staging system for residual disease that could be used for Ependymoma II...
November 2016: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://www.readbyqxmd.com/read/27511144/shooting-for-the-moon-and-the-stars
#18
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
August 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27396632/pancreatic-cancer-cause-for-optimism
#19
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
July 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27301024/impact-of-brexit-on-cancer-care-and-research
#20
EDITORIAL
The Lancet Oncology
No abstract text is available yet for this article.
May 2016: Lancet Oncology
keyword
keyword
86611
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"